[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"notifications-list":3,"$fjzm7r800h5yr":5},{"data":4},[],{"data":6,"error":11},{"id":7,"documentId":8,"slug":9,"name":10,"medical_code":11,"short_description":12,"alternate_name":11,"disambiguating_description":11,"citations":13,"drugs":25,"specialties":31,"cover":11},868,"thpe1zu81x3diu09lu4cg659","aldosterone-antagonist","Aldosterone Antagonist",null,"A class of agents that act by selectively inhibiting aldosterone receptor activation with diuretic activity. Aldosterone receptor antagonists bind to and block the activation of aldosterone (mineralocorticoid) receptors on the epithelial cells in the late distal tubule and collecting duct of the kidney, thus preventing the synthesis of aldosterone-induced proteins which enhance Na+ retention and K+ and H+ secretion. The enhanced excretion of Na+ produces diuresis ultimately resulting in a reduction in blood pressure without the loss of K+.",[14,20],{"source":15,"licence":16,"source_url":17,"harvested_by":18,"retrieved_at":19},"RxClass (NLM)","US public domain","https:\u002F\u002Frxnav.nlm.nih.gov\u002FREST\u002Frxclass\u002Fclass\u002FbyId.json?classId=N0000175557","load-reference-corpus.cjs","2026-09-13",{"source":21,"licence":22,"source_url":23,"harvested_by":18,"retrieved_at":24},"NCI Thesaurus (via NCI Metathesaurus C3536833)","NCI Thesaurus. NCI's own archived Terms of Use, still served at evs.nci.nih.gov, state: \"Permission is hereby granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the NCI THESAURUS(TM) ontology, NCI THESAURUS(TM) Users' Guide, and the NCI THESAURUS(TM) database for any commercial or non-commercial purpose\". The OBO Foundry registry records the current NCIt licence as CC BY 4.0. NCI's live licence URL https:\u002F\u002Fevs.nci.nih.gov\u002Flicense redirected to the EVS home page when checked 2026-09-16, so no first-party CURRENT licence text could be captured.","https:\u002F\u002Fapi-evsrest.nci.nih.gov\u002Fapi\u002Fv1\u002Fconcept\u002Fncit\u002FC101255?include=full","2026-09-16",[26],{"id":27,"documentId":28,"slug":29,"name":30,"active_ingredient":30,"dosage_form":11,"administration_route":11},1601,"nvm3340nvvhxrxtdrchsm7nt","spironolactone","Spironolactone",[]]